Appointment of Woman Director
Alpa Laboratories Ltd has informed BSE that Ms.Shashi Jain has been appointed as a Director of the Company with effect from March 31, 2015 for a period of 5 years by the Board of Directors of the Company.Ms Shashi Jain is a Woman Director under the provisions of Section 149(1) and (2) of the Companies Act, 2013. Financial Results & Limited Review for Dec 31, 2014 (Standalone)
Alpa Laboratories Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014. Closure of Trading Window
Alpa Laboratories Ltd has informed BSE regarding Closure of Trading Window. Shareholding Pattern For December 31, 2014
Alpa Laboratories Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014. Financial Results & Limited Review for Sept 30, 2014 (Standalone)
Alpa Laboratories Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014. Closure of Trading Window
Alpa Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 14, 2014, inter alia, to consider and approve the financial results for the quarter and period ended September 30, 2014.Further, in terms of the Code for Corporate Disclosure Practices and Code of Conduct for Prevention of Insider Trading pursuant to the provisions of Securities and Exchange Board of India (Prohibition of... Shareholding Pattern For September 30, 2014
Alpa Laboratories Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014. Disclosure of Voting results of AGM (Clause 35A)
Alpa Laboratories Ltd has informed BSE regarding the details of Voting results at the 26th Annual General Meeting (AGM) of the Company held on September 30, 2014, under Clause 35A. Sale of Unit-II (High Potency Oral Solid Dosage manufacturing unit) situated at Pithampur near Indore
Alpa Laboratories Ltd has informed BSE that subsequent to the Shareholders approval dated April 04, 2014, the Company has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited (Buyer). The Company has received a consideration of Rs. 64,00,00,000 (Rs. Sixty Four Crore Only) towards the Business Transfer Agreement (BTA) as a going concern on a slump... Outcome of AGM
Alpa Laboratories Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on September 30, 2014.